Introduction
The CCAAT-binding transcription factor NF-Y is a heteromeric protein composed of three subunits, NF-YA, NF-YB and NF-YC, all necessary for CCAAT-binding. NF-YB and NF-YC tight association is a prerequisite for NF-YA binding and sequence-specific DNA interactions. NF-YA and NF-YC have Q-rich activation domains. Both NF-YB and NF-YC contain putative histone fold motifs (Mantovani, 1999) . The CCAAT motif is present in 25% of eukaryotic promoters and NF-Y has been shown to bind over 120 of these (CCAAT-containing) promoters (Mantovani, 1998) . In accordance with the widespread presence of CCAAT boxes, NF-Y subunits are extremely conserved and have been identified in several eukaryotic kingdoms (Mantovani, 1999) .
The NF-Y complex supports the basal transcription of a class of regulatory genes responsible for cell cycle progression, among which cyclin A, -B1, -B2, cdc25B, cdc25C, and cdk1 (Farina et al., 1999; Bolognese et al., 1999; Korner et al., 2001; Zwicher et al., 1995a; Zwicher et al., 1995b) . Consistent with this, the overexpression of a dominant negative mutant of the NF-YA subunit that inhibits DNA binding of the endogenous NF-Y results in retardation of fibroblast growth (Hu et al., 2000) . We previously demonstrated that the cyclin B1 promoter activity is switched off during myogenic differentiation due to the loss of a functional NF-Y complex (Farina et al., 1999) . This evidence supports the hypothesis that the transcription of several cell cycle regulatory genes is down regulated in differentiated muscle cells trough the loss of NF-Y activity.
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The differential expression of NF-YA, resulting in an alteration of NF-Y CCAAT binding activity, has been observed in several cell lines both during cell cycle progression and under specific conditions. NF-YA expression is modulated during the cell cycle, being high in G1, further increasing in S and then decreasing in the G2/M phase (Bolognese et al., 1999) . Reduction of NF-YA expression has been reported in IMR-90 fibroblasts after serum-deprivation and in human monocytes (Chang and Liu, 1994; Marziali et al., 1997) . Complete down-regulation of NF-YA protein expression occurs in terminally differentiated C2C12 muscle cells. The loss of NF-YA expression results in the loss of a functional NF-Y complex suggesting that, although NF-Y is a ubiquitous transcription factor, differential expression of NF-YA subunit can occur during growth and differentiation of different cell lines (Farina et al., 1999) .
Permanent down-regulation of the NF-YA subunit could play a particularly important role in reducing the expression of several cell cycle control genes in differentiated muscle cells. In the present study we show that NF-YA is not expressed in the nuclei of adult skeletal and cardiac muscle tissues, while NF-YB and NF-YC are still expressed. Consistent with this, by chromatin immunoprecipitation and genomic footprinting experiments, we demonstrate that in vivo cell cycle regulatory genes are targets for the NF-Y binding activity only in proliferating muscle cells. Interestingly, forced expression of NF-YA in cells committed to differentiate leads to a reduction in the down-regulation of cyclin B1, cyclin A, and cdk1 expression. Moreover, exogenous NF-YA protein interferes 5 with the induction of p21, cyclin D3 and myogenin expression occurring early during muscle differentiation.
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MATERIALS AND METHODS
Cell culture. The mouse myoblast C2C12 cell line (Blau et al., 1985) , a clone derived from the C2C12 cell line (Yaffe and Saxel, 1977) , was cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (P). Differentiation was induced by plating the cells into collagen-coated dishes and switching them for 72 h (TD) to serum free (SF) medium: DMEM supplemented with Redu-Ser (Upstate Biotechnology Incorporated, Lake Placid, NY) to a final concentration of 5 µg/ml human insulin, 5 µg/ml human (holo) transferrin, and 5 ng/ml sodium selenite. 50 µM cytosine arabinoside (Ara-C) was added to the SF medium to eliminate undifferentiated cells. As previously described (Tiainen et al., 1996) , under these conditions more than 90% of the cells become terminally differentiated (TD). For the analysis of cell cycle control and muscle specific gene expression after over-expression of NF-YA protein (Fig.   6 ), the cells were induced to differentiate in the absence of Ara-C for 6hr, 12hr, 24hr, 48hr.
Total cell and tissue lysates and Western Blot analysis. Total-cell extracts were prepared by incubating C2C12 cells in 0,15M NaCl buffer containing 50mM
Tris-HCl (pH 8), 5mM EDTA, 1% NP-40, 0.5% DOC, 10 µg/ml leupeptin, 4 µg/ml pepstatin, 5 µg/ml aprotinin, 50mM NaF, 1mM NaOrthovanadate, 1mM PMSF.
BDF1 wild type adult mice were sacrificed by vertebral dislocation. Organs were dissected, immediately frozen in liquid nitrogen, and stored at -70°C until used.
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Purified muscle and fibroblast were obtained by treatment of the tissue with trypsin, collagenase and mechanical disruption (Porrello et al., 2000) . Totaltissue extracts were prepared by homogenization in lysis buffer (20mM Tris-HCl pH8, 1%NP-40, 10% glycerol, 137mM NaCl, 5mM EDTA pH8, 5mM EGTA pH7, 1mM NaOrthovanadate, 50mM NaF, 5 µg/ml Aprotinin, 10 µg/ml Leupeptin, 10mM PMSF) on dry ice. 50 µg of total C2C12 lysate and 150 µg of total tissue lysate were separated by SDS-polyacrylamide gel electrophoresis (12.5%) and electroblotted onto nitrocellulose. After blocking with 5% non-fat dried milk, the filters containing tissue lysates were immunoreacted with each of the following antibodies: anti-NF-YA rabbit polyclonal antibody (0.3 µg/ml) (Rockland), anti-NF-YB rabbit polyclonal antibody (0.3 µg/ml) (Mantovani et al., 1994) , anti-NF-YC rabbit polyclonal antibody (0.3 µg/ml) (Mantovani et al.,1994) , anti-Hsp70 mouse monoclonal antibody (0.25 µg/ml) (Stress Gen, Biotechnologies Corp., Victo-ria Canada). The filters containing C2C12 lysates were immunoreacted with 0.3 µg/ml anti-NF-YA rabbit polyclonal antibody (Rockland), 0.1 µg/ml anti-cyclin B1 rabbit polyclonal antibody, 0.1 µg/ml anti-cyclin A rabbit polyclonal antibody, 0.1 µg/ml anti-cdk1 p34 rabbit polyclonal antibody, 1 µg/ml anti-myogenin rabbit polyclonal antibody (Santa Cruz Biotechnology, Inc. California), 1:500 anti-mouse p21 (kindly provided by C. Schneider), rabbit polyclonal antibody 0.25 µg/ml anti- anti-NF-YB rabbit polyclonal antibody (Mantovani et al., 1994) down, 5'-GGG GAG AGG GGC GGG GCC ACA G. Production and purification of recombinant NF-YA protein were previously described (Mantovani et al., 1994) .
Formaldehyde cross-linking and chromatin immunoprecipitations (ChIPs).
Formaldehyde cross-linking and chromatin immunoprecipitations were performed as previously described (Fontemaggi et al., 2001) . 
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In vivo DNA footprinting. The in vivo DNA footprinting was performed by using LM-PCR as described (Dey et al., 1992) . Proliferating (P) and terminally differentiated (TD) cells were treated with 0.1% dimethyl sulfate (DMS) for 2 min.
After DMS treatment, cells were washed three times with cold phosphatebuffered saline (PBS). DNA was isolated and cleaved with piperidine. Labeled PCR products were resolved on a 6% polyacrylamide-8M urea sequencing gel. In performed as described previously (Farina et al., 1999) . CAT or Luc-reporter constructs carrying the cyclin B1 (Piaggio et al., 1995) , cdk1 (Dalton, 1992) , cyclin A (Schulze et al., 1995) , cyclin B2 (Bolognese et al., 1999) , cdc25A (Vigo et al., 1999) , cdc25C (Manni et al., 2001) , and cyclin E (Botz et al., 1996) 
Results
NF-YA is not expressed in adult muscle tissues.
To start to investigate NF-Y expression in vivo we performed western blots on total protein extracts from different murine adult tissues. Figure 1A shows that, the NF-YB and NF-YC subunits are expressed in all tested tissues, although to a different extent, whereas NF-YA is not detectable even upon longer exposure in skeletal muscle and heart. To confirm these observations in intact cells we performed immuno-hystochemical analyses on murine skeletal and cardiac muscle tissues. The anti-NF-YA antibody did not show immunoreactivity in skeletal muscle or heart sections, whereas staining with this antiboby was observed in brain. In contrast to this, an anti-NF-YB antibody showed immunoreactivity in muscle and heart as well as in brain (Fig.1B) . We conclude that, apparently, NF-YA is not ubiquitously expressed, being undetectable in adult skeletal muscle and heart tissues, while the NF-YB/NF-YC heterodimer is ubiquitously expressed, being detectable in all tissues tested.
The CCAAT binding activity of NF-Y is lost in adult muscle tissues.
To assess whether loss of the NF-YA subunit leads to loss of the CCAAT binding activity of NF-Y we performed electromobility shift assays with extracts from adult mouse tissues, using an oligo containing the cyclin B1 CCAAT box (Farina et al., 1999 ). The results demonstrate that the DNA binding activity of NF-Y is lost in skeletal and cardiac muscle extracts while, as expected, is present in the other tested tissues (Fig.2A) . The lack of NF-Y binding to the CCAAT box in muscle 15 and heart is due to the loss of the NF-YA protein as demonstrated by EMSA experiments performed in the presence of recombinant purified NF-YA protein.
As shown in figure 2B , 
NF-Y does not bind cell cycle dependent promoters in terminally differentiated cells in vivo.
NF-Y supports the basal transcription of a class of regulatory genes responsible for cell cycle progression, among which cyclin A, -B1, -B2, cdc25B, cdc25C, and cdk1 (Manni et al., 2001; Farina et al., 1999; Bolognese et al., 1999; Korner et al., 2001; Zwicher et al., 1995a; Zwicher et al., 1995b) . To investigate the DNA binding activity of NF-Y on cell cycle target promoters in terminally differentiated cells, we performed chromatin immunoprecipitation (ChIP) experiments on proliferating (P) and terminally differentiated (TD) C2C12 skeletal muscle cells.
Proliferating cells were induced to differentiate by growth factors withdrawal for 72 hours (Tianen et al., 1996) . Proliferating and differentiated cells were treated with formaldehyde to crosslink proteins to DNA. After sonication, the crosslinked chromatin from equivalent numbers of P and TD cells was immunoprecipitated by 16 using anti-NF-YB or anti-NF-YA antibodies. As negative controls, we included a reaction lacking primary antibody and one containing an anti-E2F1 antibody.
E2F1 is a nuclear transcription factor that does not have a binding site on the cyclin B2 promoter. After immunoprecipitation, enrichment for the endogenous cyclin B2 and A promoter fragments in each sample was assessed by PCR amplification using primers amplifying the cyclin B2 promoter region from -145 to +90 bp, and the cyclin A promoter region from -143 to +89 bp, respectively. As shown in figure 3 , the anti-NF-YB and the anti-NF-YA antibodies did not 2, 13, 14) . The anti-E2F1 antibody was unable to immunoprecipitate cyclin B2 promoter from both cell types (lanes 3 and 9), while it immunoprecipitated the cyclin A promoter in proliferating cells (lane 15). This result is in agreement with recent data demonstrating that E2F1 binds to the cyclin A promoter in proliferating glioblastoma cells (Takahashi et al., 2000) .
It has been described that the CCAAT displacement protein is able to displace NF-Y from several promoters containing CCAAT boxes (Nepveu 2001) . Thus, we asked whether in differentiated cells the CCAAT boxes of the cyclin B2 and cyclin A promoters are bound by proteins, other than NF-Y. To answer this question we performed in vivo genomic footprinting analysis of both promoters. Proliferating and differentiated C2C12 cells were treated with the DNA alkylating reagent dimethyl sulfate (DMS), and methylated G-residues were identified using the ligation-mediated polymerase chain reaction technique (LM-PCR) (Dey et al., 1992) . As shown in figure 4 , in proliferating cells the CCAAT boxes of both the cyclin B2 and cyclin A promoters were protected from DMS methylation (lanes 3, 6). By contrast, the CCAAT boxes and the flanking regions of these promoters were devoid of interactions with proteins in differentiated cells (lanes 2, 4).
Taken together, these results provide further in vivo evidence for a lack of NF-Y binding activity to the CCAAT boxes of the cell cycle target promoters in skeletal muscle differentiated cells.
The promoter activities of NF-Y-target cell cycle genes are down-regulated in differentiated muscle cells.
We queried whether the lack of NF-Y binding activity to the CCAAT boxes leads to down-regulation of the activities of CCAAT containing promoters in terminally differentiated cells. To this end, C2C12 cells were stably transfected with CAT reporter constructs carrying human cyclin B1 (Piaggio et al., 1995) , and human cdk1 (Dalton, 1992) promoter fragments, and luciferase reporter constructs carrying human cyclin A (Schulze et al., 1995) , murine cyclin B2 (Bolognese et al., 1999) , human cdc25A (Vigo et al., 1999) , human cdc25C (Manni et al., 2001 ), murine cyclin E (promoter fragments. Except for cyclin E promoter, it has been demonstrated that NF-Y contributes to support the basal activity of these promoters in proliferating cells (Sciortino et al., 2001; Manni et al., 2001; Farina et al., 1999; Jung et al., 2001; Yun et al., 1999; Liu et al., 1998; Zwicher et al., 1995a; Kramer et al. 1997; Plet et al., 1997; Botz et al., 1996 , Huet et al., 1996 Zwicher et al., 1995b) . Figure 5 shows that all of promoter constructs are capable of driving transcription only in proliferating cells, while their activities are down regulated in TD cells. Interestingly, the cyclin E promoter fragment that does not contain CCAAT boxes is still active in TD cells.
Forced expression of NF-YA during the muscle differentiation program
inhibits the down-regulation of several cell cycle gene expression and the induction of p21, myogenin and creatine kinase activity.
Normal differentiation of myoblasts is accompanied by a change in the expression of both cell cycle and muscle specific genes. Initiation of muscle specific gene expression during differentiation of muscle cells is preceded by withdrawal of the cells from the cell cycle (Crescenzi et al., 1990 , Sorrentino et al., 1990 . Cell cycle arrest is a requirement for muscle differentiation and it is accomplished by down-regulation of cyclins, with the exception of cyclin D3, which is up-regulated during differentiation and contributes to cell cycle withdrawal (Farina et al., 1999) . Moreover, Consistent with this NF-YA over-expression leads to a delay in the induction of myogenin, an early muscle differentiation marker, while there was no effect on MyoD expression (Sassoon et al, 1993; Buckingam, 1994; Tiainen et al., 1996) .
We next examined the activity of creatine kinase, a muscle-specific enzyme marker, in cell lysates. As shown in Fig. 6 (Fig 7A, B) . As expected for promoters that do not contain CCAAT boxes, the dominant-negative as well as the wild type NF-YA proteins do not modulate the activities of both promoters. By contrast, the activities of p21 and myogenin promoters are induced by p53 and serum deprivation respectively as described (D'orazi et al., 2002; Edmondson et al., 1992) .
Discussion
The results presented in this study show that the CCAAT binding activity of the NF-Y transcription factor is absent in adult skeletal and cardiac muscle tissues and that loss of this activity is due to the down-regulation of the NF-YA protein in these tissues. The relevance of this observation resides in the fact that recent studies, in various cell types, have indicated that NF-Y could serve as a common transcription factor for an increasing number of cell cycle control genes. For instance, the cyclin B1, cyclin B2, cyclin A, cdc25B cdc25C, and cdk1 genes all contain in their promoters NF-Y sites, which are required for their transcriptional activation at S phase (Bolognese et al., 1999; Korner and Muller., 2001; Manni et al., 2001; Zwicher et al., 1995a; Zwicher et al., 1995b) . We have already demonstrated that the loss of a functional NF-Y complex in differentiated muscle cells leads to down-regulation of the cyclin B1 promoter (Farina et al., 1999) . We that the CCAAT box is present in 63% of them (Suzuki et al., 2001 ). It will be of interest to investigate whether the transcription from other CCAAT-containing promoters, in post-mitotic skeletal muscle cells, is down regulated by the same common mechanism presently described.
In adult muscle tissues the expression of NF-YA protein is down regulated, while NF-YB and -C are still expressed. It has been demonstrated that the NF-Y histone-like dimer, NF-YB/C, can form complexes with H3-H4 histones for whose formation the CCAAT box is not required. Moreover, the NF-Y histone-like dimer associates with DNA during nucleosome formation in the absence of NF-YA (Caretti et al., 1999) . Proteins involved in histone acetylation are found associated with NF-YB (Currie, 1998 , Li et al., 1998 cycle. Since the induction of p21, cyclin D3, and myogenin Molkentin and Olson, 1996) , as well as the down-regulation of the of cell cycle control genes (Perry and Rudnick, 2000) are important events in the induction of muscle differentiation, our data suggest that NF-Y exerts a biological role in the switch from proliferation to differentiation of muscle cells.
Although the presence of NF-YA in cells committed to differentiate could lead to conflicting signals, no apparent apoptosis was seen in our experimental conditions. It remains to be determined whether expression of NF-YA in the presence of differentiation stimuli for periods of time longer than those tested here, leads to apoptosis. Indeed, the level of NF-YA drops between 24 and 48 24 hours in the transfected cells and after 72 hours of growth factor withdrawal it becomes undetectable (our unpublished results). This could explain why overexpression of NF-YA can only delay rather than inhibit differentiation.
Our previous results indicate that the regulation of NF-YA expression depends on a post-transcriptional level of regulation (Farina et al., 1999) . Based on these consideration we tested the effect of the specific calpain I and II and catepsin 2, 7, 8, 13, 14, 19, 20) , E2F1
(lanes 3,9,15,21) or no antibody (4, 10, 16, 22) . Immunoprecipitates from each antibody were aliquoted and then analyzed by PCR with specific primers for the mouse cyclin B2 or cyclin A promoters. A sample representing 0,02% of the total input chromatin (input) was included in the PCR reactions. 
